No Data Available
Plethico Pharmaceuticals Share Price
Loading...
| Open | - |
| High | 9.05 |
| Low | 9.05 |
| Prev Close | - |
| Volume | 200 |
| VWAP(₹) | - |
Stock not traded on NSE/BSE
Key Metrics
| PE Ratio(x) | - |
| EPS - TTM(₹) | - |
| MCap(₹ Cr.) | - |
| MCap Rank | - |
| PB Ratio(x) | - |
| Div Yield(%) | - |
| Face Value(₹) | - |
| 52W High(₹) | - |
| 52W Low(₹) | - |
| MCap/Sales | - |
| Beta(1 Month) | - |
| BV/Share(₹) | - |
Plethico Pharmaceuticals Ltd. share price insights
We don’t have any Insights for this stock currently.
Plethico Pharmaceuticals Ltd. Share Price Returns
| 1 Day | N.A. |
| 1 Month | N.A. |
| 3 Months | N.A. |
| 1 Year | N.A. |
| 3 Years | N.A. |
| 5 Years | N.A. |
Plethico Pharmaceuticals Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
News & Analysis
News
BSE to shift 17 stocks, NSE 2 scrips to 'T' group from Aug 24
News
BSE to drop ING Vysya Bank from BSE 200, BSE 500 indicesBuying PlethicoPharma now poses risk: Deepak Mohoni
NewsShareholding for the Period Ended June 30, 2016
Announcements
Financials
Quarterly Mar 2015 Dec 2014 Sep 2014 Jun 2014 Mar 2014 Total Income 112.69 111.58 263.39 277.47 310.22 Total Income Growth (%) 1.00 -57.64 -5.07 -10.56 -14.85 Total Expenses 473.30 103.94 226.73 242.47 277.52 Total Expenses Growth (%) 355.37 -54.16 -6.49 -12.63 -4.98 EBIT -360.61 7.64 36.66 35.01 32.70 EBIT Growth (%) 0.00 -79.17 4.73 7.05 -54.74 Profit after Tax (PAT) -265.67 -4.07 -6.31 -1.68 -11.98 PAT Growth (%) - - - - -127.20 EBIT Margin (%) -320.00 6.85 13.92 12.62 10.54 Net Profit Margin (%) -235.75 -3.64 -2.39 -0.60 -3.86 Basic EPS (₹) -58.28 -1.19 -1.85 -0.49 -3.52 No Data Available
No Data Available
No Data Available
Found Financials useful?
Technicals
No Data Available
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
- There’s no suggested peer for this stock.
Mutual Funds Ownership
No Data Available
Plethico Pharmaceuticals Ltd. Top Searches
Corporate Actions
Board Meeting
Audited Results
Mar 09, 2016
Board Meeting
Others
Dec 03, 2015
General Meeting
-
Dec 03, 2015
Announced on Meeting on Mar 09, 2016 Mar 14, 2016 Audited Results Dec 03, 2015 Dec 03, 2015 Others May 22, 2015 May 29, 2015 Audited Results Apr 01, 2015 Mar 31, 2015 Others Feb 06, 2015 Feb 14, 2015 Quarterly Results Announced on Ex-Date Dividend% Mar 31, 2011 Sep 22, 2011 25% Mar 31, 2010 Jun 24, 2010 25% Apr 01, 2009 Jun 18, 2009 25% May 27, 2008 Jun 20, 2008 25% Dec 28, 2006 Mar 23, 2007 25% Announced on Ex-Date Jun 01, 2013 - Bonus Ratio: 5 share(s) for every 1 shares held Announced on Ex-Date May 27, 2008 - Split: Old FV10.0| New FV:1.0 No Data Available
Announced on Meeting on Dec 03, 2015 Dec 29, 2015 - Aug 13, 2014 Dec 26, 2014 AGM Revised from 20/09/2014 May 14, 2013 Jun 28, 2013 Book closure from Jun 25, 2013 to Jun 28, 2013 Mar 13, 2013 Apr 05, 2013 - Jun 08, 2012 Jun 29, 2012 Book closure from Jun 27, 2012 to Jun 29, 2012
About Plethico Pharmaceuticals
Industry
Key Indices Listed On
-
Address
A B Road, MangliaIndore, Madhya Pradesh - 453771
Executive Leadership
No Data Available
Auditors
No Data Available
Top Gainers
As on 03:59 PM | 15 Jun 2026Top Losers
As on 03:58 PM | 15 Jun 2026Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.